17 New Mexico Women File Joint Talcum Powder Lawsuit
More than a dozen have filed a baby powder cancer lawsuit against Johnson & Johnson, claiming the company was responsible for their contractions of ovarian cancer allegedly caused by the company's talcum powder products.
Friday, May 20, 2016 - A group of 17 plaintiffs in New Mexico have filed a joint talcum powder ovarian cancer lawsuit against Johnson & Johnson. The group is made of of 15 women and the estates of two others who have passed away. All of the plaintiffs claim that Johnson & Johnson knew of the ovarian cancer risk their talcum powder products posed but decided against properly warning consumers by listing pertinent information via warning labels. These Johnson & Johnson's baby powder lawsuits join more than 1,000 currently pending nationwide against the health care giant.
The New Mexico talcum powder cancer lawsuit is the most recent to be filed against Johnson & Johnson. Mounting evidence from decades of talcum powder research and internal documents recovered by baby powder cancer lawyers have led to the widespread legal action being taken against the health care company. Johnson & Johnson has claimed that it relied on research that demonstrated no ovarian cancer link existed concerning its talcum powder products, but more than a dozen medical studies have bolstered the plaintiffs legal arguments and led to two sizeable victories in 2016.
The two legal wins for plaintiffs came before the City of St. Louis Circuit Court, where a pair of talcum powder ovarian cancer lawsuits were awarded a combined $127 million in damages. The juries in both cases found that Johnson & Johnson had been aware of the medically researched ovarian cancer link to its talcum powder products but decided against sufficiently warning consumers, putting them at an unnecessary risk for the disease. Plaintiffs claimed that Johnson & Johnson feared for the marketing hit their talcum powder products would take, being one of the company's flagship products, and elected to keep their knowledge of potential health risks shrouded behind a handful of studies that supported the lack of an ovarian cancer link.
The filing of the New Mexico talcum powder cancer lawsuit demonstrates the reach the litigation has had around the country. As news of the large settlements have spread, law firms have been vigorously reviewing talcum powder claims to find legitimate cases it can bring against Johnson & Johnson. The women filing Johnson & Johnson's baby powder lawsuits also come from diverse backgrounds. The ages of the women in the New Mexico talcum powder ovarian cancer lawsuit range from the 20s-60s, and there has even been claims that the health care company targeted Black and Hispanic communities specifically after they had discovered the carcinogenic properties of their baby powder products.
The New Mexico Johnson & Johnson's baby powder lawsuit will likely seek similar damages, but may not reach a trial as many in the legal world anticipate a lump sum settlement if Johnson & Johnson continues to be penalized hefty damages in court. With more than 1,000 talcum powder ovarian cancer lawsuits filed, the company may attempt to settle most of these outside of court where the damages as a whole would be far less than continuing to hear the lawsuits individually. The new talcum powder ovarian cancer lawsuit is scheduled to begin in September, once again before the City of St. Louis Circuit Court.